Company
Company Information
History
Access
R&D
Technology
Technology Platform
NJA-730
Napa9-SPG
Business Development
Drug Discovery and Development Collaboration
Licensing Opportunity
News
Press release
Academic
Contact
HOME
»
news
news Archives
2020-10-08
news
NapaJen Pharma Reports Positive Results from Phase 1 Clinical Trial of Novel RNA Interference (RNAi) Therapeutic
